Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Hims & Hers Health Stock Just Popped

TheMotleyFool 
0 0 11.03.25
Why Hims & Hers Health Stock Just PoppedPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
 

Roller-coaster healthcare stock Hims & Hers Health (NYSE: HIMS), whose stock got devastated last week by worries that it would be shut out of the GLP-1 market, got a reprieve from the Food and Drug Administration (FDA) on Monday.

Shares of the pharmaceutical upstart are flying Tuesday morning -- up 7.3% through 10:20 a.m. ET.

Last week, the news on Hims & Hers was all about how a Texas court ruling confirmed the FDA can declare an end to the shortage of tirzepatide-based GLP-1 weight-loss drugs from Eli Lilly (NYSE: LLY), just as it had previously called an end to the shortage of Novo Nordisk's (NYSE: NVO) similar semaglutide-based Ozempic. But yesterday, the FDA clarified its own opinion on the matter.

Continue reading


Source Fool.com

Like: 0
HIMS
Share

Comments

Not a member yet? Sign up for free!